Literature DB >> 25981460

Mathematical optimization of contrast concentration for T1-weighted spoiled gradient echo imaging.

Scott B Reeder1,2,3,4,5, Matthew R Smith1, Diego Hernando1.   

Abstract

PURPOSE: To develop and validate closed form mathematical expressions that predict the optimal contrast agent concentration for the maximum T1-weighted spoiled gradient echo (SGRE) signal. THEORY AND METHODS: Gadolinium and iron-based contrast agents can have significant transverse relaxivity that leads to signal dropout with increasing contrast agent concentration. A mathematical expression for the "optimal" contrast agent concentration where recovery of longitudinal magnetization is offset by increasing transverse signal decay was derived. Expressions for the maximum possible SGRE signal were also derived. Three phantoms were constructed, each with varying concentrations of one of the following three agents: gadoteridol, gadobenate dimeglumine, and ferumoxytol. After measuring the longitudinal and transverse relaxivity of the three agents, the SGRE signal was measured in the phantoms over a wide range of flip angles and echo times.
RESULTS: Excellent qualitative agreement between the SGRE signal behavior, optimal concentration, and optimal flip angle were observed between experimental measurements and theoretical predictions.
CONCLUSION: This work provides validated mathematical expressions for contrast enhanced T1-weighted SGRE imaging and may provide guidance for contrast dosing and injection protocols, as well as for novel pulse sequence design.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  T1-weighted imaging; contrast dose; ferumoxytol; gadolinium; magnetic resonance imaging; spoiled gradient echo imaging

Mesh:

Substances:

Year:  2015        PMID: 25981460     DOI: 10.1002/mrm.25744

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  6 in total

1.  Quantitative comparison of delayed ferumoxytol T1 enhancement with immediate gadoteridol enhancement in high grade gliomas.

Authors:  Andrea Horváth; Csanad G Varallyay; Daniel Schwartz; Gerda B Toth; Joao P Netto; Ramon Barajas; Péter Várallyay; László Szidonya; Jenny Firkins; Emily Youngers; Rongwei Fu; Prakash Ambady; Péter Bogner; Edward A Neuwelt
Journal:  Magn Reson Med       Date:  2017-12-04       Impact factor: 4.668

2.  Incidental ferumoxytol artifacts in clinical brain MR imaging.

Authors:  Bruce A Bowser; Norbert G Campeau; Carrie M Carr; Felix E Diehn; Jennifer S McDonald; Gary M Miller; Timothy J Kaufmann
Journal:  Neuroradiology       Date:  2016-10-04       Impact factor: 2.804

Review 3.  Safety and technique of ferumoxytol administration for MRI.

Authors:  Shreyas S Vasanawala; Kim-Lien Nguyen; Michael D Hope; Mellena D Bridges; Thomas A Hope; Scott B Reeder; Mustafa R Bashir
Journal:  Magn Reson Med       Date:  2016-02-18       Impact factor: 4.668

4.  Crossover comparison of ferumoxytol and gadobenate dimeglumine for abdominal MR-angiography at 3.0 tesla: Effects of contrast bolus length and flip angle.

Authors:  Tilman Schubert; Utaroh Motosugi; Sonja Kinner; Timothy J Colgan; Samir D Sharma; Scott Hetzel; Shane Wells; Camilo A Campo; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2016-11-10       Impact factor: 4.813

5.  Relaxivity of Ferumoxytol at 1.5 T and 3.0 T.

Authors:  Gesine Knobloch; Timothy Colgan; Curtis N Wiens; Xiaoke Wang; Tilman Schubert; Diego Hernando; Samir D Sharma; Scott B Reeder
Journal:  Invest Radiol       Date:  2018-05       Impact factor: 6.016

6.  Blood volume measurement using cardiovascular magnetic resonance and ferumoxytol: preclinical validation.

Authors:  Rajiv Ramasawmy; Toby Rogers; Miguel A Alcantar; Delaney R McGuirt; Jaffar M Khan; Peter Kellman; Hui Xue; Anthony Z Faranesh; Adrienne E Campbell-Washburn; Robert J Lederman; Daniel A Herzka
Journal:  J Cardiovasc Magn Reson       Date:  2018-09-10       Impact factor: 5.364

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.